Among key regulators of anti-tumor immunity, PD-L1, PD-1, FOXP3, and miR-155 have emerged as key modulators of immune evasion and tumor progression in several malignancies, including OSCC [7,16,38,39]. This evidence concerns the gene PDCD1 and neoplasm.